4
Changes in Ownership
Prelude Therapeutics Inc Filed Acc 0001562180-23-007230
President, CMO acquired 9,375 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Huang Jane President, CMO | 2023-10-04 | Option exercise | +9,375 | 39,728 | D | ||
| Derivatives | |||||||
| Huang Jane President, CMO | 2023-10-04 | Option exercise · Restricted Stock Unit | +9,375 | 93,750 | D | ||
Loading xslF345X05/primarydocument.xml…